Outcome Prediction After Coronary Surgery and Redo Surgery for Bleeding (From the KROK Registry)

A Novel Antidote-Controlled Anticoagulant Reduces Thrombin Generation and Inflammation and Improves Cardiac Function in Cardiopulmonary Bypass Surgery

Here we demonstrate that an anticoagulant aptamer-antidote pair targeting factor IXa can replace heparin and protamine in a porcine CPB model and also limit the adverse effects on thrombin generation, inflammation, and cardiac physiology associated with heparin and protamine use.

Long-term Outcomes of Coronary Artery Bypass Grafting Patients Supported Preoperatively with an Intra-Aortic Balloon Pump

In patients supported preoperatively with an IABP, better early and long-term results were strongly related to younger age,